The tone of pulmonary smooth muscle: ROK and Rho music?

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 287, Issue 4 31-4, 2004, Pages

  Sylvester, J T ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FASUDIL; RHO FACTOR; RHO KINASE; SALBUTAMOL; SALMETEROL;

HUMAN; LUNG VENTILATION PERFUSION RATIO; MUSCLE FUNCTION; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PULMONARY HYPERTENSION; SMOOTH MUSCLE TONE;

ANIMALS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG; MUSCLE, SMOOTH; PROTEIN-SERINE-THREONINE KINASES; RHO GTP-BINDING PROTEINS;

EID: 4544298268     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00215.2004     Document Type: Note

References (92)

1. Aalkjaer C and Peng HL. pH and smooth muscle. Acta Physiol Scand 161: 557-566, 1997.
2. Abe K, Shimokawa H, Morikawa K, Uwatoku T, Oi K, Matsumoto Y, Hattori T, Nakashima Y, Kaibuchi K, Sueishi K, and Takeshit A. Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circ Res 94: 385-393, 2004.
3. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, and Kaibuchi K. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271: 20246-20249, 1996.
4. Asano M and Nomura Y. Comparison of inhibitory effects of Y-27632, a Rho kinase inhibitor, in strips of small and large mesenteric arteries from spontaneously hypertensive and normotensive Wistar-Kyoto rats. Hypertens Res 26: 97-106, 2003.
5. Ayman S, Wallace P, Wayman CP, Gibson A, and McFadzean I. Receptor-independent activation of Rho-kinase-mediated calcium sensitisation in smooth muscle. Br J Pharmacol 139: 1532-1538, 2003.
6. Bailly K, Ridley AJ, Hall SM, and Haworth SG. RhoA activation by hypoxia in pulmonary arterial smooth muscle cells is age and site specific. Circ Res 94: 1383-1391, 2004.
7. Barbieri JT, Riese MJ, and Aktories K. Bacterial toxins that modify the actin cytoskeleton. Annu Rev Cell Dev Biol 18: 315-344. 2002.
8. Boer C, van Nieuw Amerongen GP, Groeneveld ABJ, Scheffer GJ, de Lange JJ, Westerhof N, van Hinsbergh VW, and Sipkema P. Smooth muscle F-actin disassembly and RhoA/Rho-kinase signaling during endotoxin-induced alterations in pulmonary arterial compliance. Am J Physiol Lung Cell Mol Physiol 287: L649-L655, 2004.
9. Brimioulle S, Lejeune P, Vachiery JL, Leeman M, Melot C, and Naeije R. Effects of acidosis and alkalosis on hypoxic pulmonary vasoconstriction in dogs. Am J Physiol Heart Circ Physiol 258: H347-H353, 1990.
10. Burridge K and Wennerberg K. Rho and Rac take center stage. Cell 116: 167-179, 2004.
11. Butler TM and Siegman MJ. Control of cross-bridge cycling by myosin light chain phosphorylation in mammalian smooth muscle. Acta Physiol Scand 164: 389-400, 1998.
12. 2+ sensitization of bronchial smooth muscle contraction in antigen-induced airway hyperresponsive rats. Br J Pharmacol 127: 597-600, 1999.
13. Davies SP, Reddy H, Caivano M, and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105, 2000.
14. 2+ sensitivity of airway smooth muscle contraction through a mechanism distinct from inhibition of Rho-kinase. Am J Physiol Lung Cell Mol Physiol 287: L641-L648, 2004.
15. Etienne-Manneville S and Hall A. Rho GTPases in cell biology. Nature 420: 629-635, 2002.
16. Eto M, Ohmori T, Suzuki M, Furuya K, and Morita F. A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization. J Biochem (Tokyo) 118: 1104-1107, 1995.
17. Eto M, Senba S, Morita F, and Yazawa M. Molecular cloning of a novel phosphorylation-dependent inhibitory protein of protein phosphatase-1 (CP117) in smooth muscle: its specific localization in smooth muscle. FEBS Lett 410: 356-360, 1997.
18. Fagan KA, Oka M, Bauer NR, Gebb SA, Ivy DD, Morris KG, and McMurtry IF. Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. Am J Physiol Lung Cell Mol Physiol 287: L656-L664, 2004.
19. Fernandes DJ, Mitchell RW, Lakser O, Dowell M, Stewart AG, and Solway J. Do inflammatory mediators influence the contribution of airway smooth muscle contraction to airway hyperresponsiveness in asthma? J Appl Physiol 95: 844-853, 2003.
20. 2+-sensitization of smooth muscle. FEBS Lett 440: 183-187, 1998.
21. Fujihara H, Walker LA, Gong MC, Lemichez E, Boquet P, Somlyo AV, and Somlyo AP. Inhibition of RhoA translocation and calcium sensitization by in vivo ADP-ribosylation with the chimeric toxin DC3B. Mol Biol Cell 8: 2437-2447, 1997.
22. Fujiwara T, Itoh T, Kubota Y, and Kuriyama H. Effects of guanosine nucleotides on skinned smooth muscle tissue of the rabbit mesenteric artery. J Physiol 408: 535-547, 1989.
23. Ghisdal P, Vandenberg G, and Morel N. Rho-dependent kinase is involved in agonist-activated calcium entry in rat arteries. J Physiol 551: 855-867, 2003.
24. 2+ sensitization of smooth muscle. J Biol Chem 272: 10704-10709, 1997.
25. 2+ sensitization of smooth muscle. Proc Natl Acad Sci USA 93: 1340-1345, 1996.
26. Gunst SJ, Tang DD, and Opazo Saez A. Cytoskeletal remodeling of the airway smooth muscle cell: a mechanism for adaptation to mechanical forces in the lung. Respir Physiol 137: 151-168, 2003.
27. Herrera AM, Martinez EC, and Seow CY. Electron microscopic study of actin polymerization in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 286: L1161-L1168, 2004.
28. 2+ sensitivity in rabbit pulmonary artery smooth muscle. Pflügers Arch 417: 21-28, 1990.
29. Hirano K, Derkach DN, Hirano M, Nishimura J, and Kanaide H. Protein kinase network in the regulation of phosphorylation and dephosphorylation of smooth muscle myosin light chain. Mol Cell Biochem 248: 105-114, 2003.
30. Hirata K, Kikuchi A, Sasaki T, Kuroda S, Kaibuchi K, Matsuura Y, Seki H, Saida K, and Takai Y. Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J Biol Chem 267: 8719-8722, 1992.
31. i-2 activation of Rho, Am J Physiol Lung Cell Mol Physiol 277: L653-L661, 1999.
32. 2+ sensitization of myosin light chain20 phosphorylation. Mol Pharmacol 63: 714-721, 2003.
33. Hyvelin J-M, O'Connor C, and McLoughlin P. Effect of changes in pH on wall tension in isolated rat pulmonary artery: role of the RhoA/Rho-kinase pathway. Am J Physiol Lung Cell Mol Physiol 287: L673-L684, 2004.
34. Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M, and Narumiya S. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 57: 976-983, 2000.
35. 2+ entry by rho-kinase in tracheal smooth muscle. Am J Respir Cell Mol Biol 26: 491-498, 2002.
36. Johnson M. The β-adrenoceptor. Am J Respir Crit Care Med 158: S146-S153, 1998.
37. Kaibuchi K, Kuroda S, and Amano M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 68: 459-486, 1999.
38. Kamm KE and Stull JT. The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol 25: 593-620, 1985.
39. Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K, Harada K, Miyamoto S, Nakazawa H, Won KJ, and Sato K. Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev 49: 157-230, 1997.
40. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, and Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273: 245-248, 1996.
41. Kitazawa T, Eto M, Woodsome TP, and Brautigan DL. Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. J Biol Chem 275: 9897-9900, 2000.
42. 2+ sensitization of smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem 266: 1708-1715, 1991.
43. 2+. J Biol Chem 264: 5339-5342, 1989.
44. Kitazawa T, Masuo M, and Somlyo AP. G protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proc Natl Acad Sci USA 88: 9307-9310, 1991.
45. Koyama M, Ito M, Feng J, Seko T, Shiraki K, Takase K, Hartshorne DJ, and Nakano T. Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase. FEBS Lett 475: 197-200, 2000.
46. Kubota Y, Nomura M, Kamm KE, Mumby MC, and Stull JT. GTP γ S-dependent regulation of smooth muscle contractile elements. Am J Physiol Cell Physiol 262: C405-C410, 1992.
47. Kureishi Y, Kobayashi S, Amano M, Kimura K, Kanaide H, Nakano T, Kaibuchi K, and Ito M. Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem 272: 12257-12260, 1997.
48. 2+ and contraction in guinea pig taenia caecum. Jpn J Pharmacol 61: 57-64, 1993.
49. Li L, Eto M, Lee MR, Morita F, Yazawa M, and Kitazawa T. Possible involvement of the novel CPI-17 protein in protein kinase C signal transduction of rabbit arterial smooth muscle. J Physiol 508: 871-881, 1998.
50. Lucius C, Arner A, Steusloff A, Troschka M, Hofmann F, Aktories K, and Pfitzer G. Clostridium difficile toxin B inhibits carbachol-induced force and myosin light chain phosphorylation in guinea-pig smooth muscle: role of Rho proteins. J Physiol 506: 83-93, 1998.
51. Luykenaar KD, Brett SE, Wu BN, Wiehler WB, and Welsh DG. Pyrimidine nucleotides suppress KDR currents and depolarize rat cerebral arteries by activating Rho kinase. Am J Physiol Heart Circ Physiol 286: H1088-H1100, 2004.
52. Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A, Obinata T, Ohashi K, Mizuno K, and Narumiya S. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 285: 895-898, 1999.
53. Mehta D and Gunst SJ. Actin polymerization stimulated by contractile activation regulates force development in canine tracheal smooth muscle. J Physiol 519: 829-840, 1999.
54. 2+ pools and Rho-kinase pathway. Am J Physiol Lung Cell Mol Physiol 287: L631-L640, 2004.
55. Mita M, Yanagihara H, Hishinuma S, Saito M, and Walsh MP. Membrane depolarization-induced contraction of rat caudal arterial smooth muscle involves Rho-associated kinase. Biochem J 364: 431-440, 2002.
56. Mitzner W. Airway smooth muscle: the appendix of the lung. Am J Respir Crit Care Med 169: 787-790, 2004.
57. Morgan JP and Morgan KG. Stimulus-specific patterns of intracellular calcium levels in smooth muscle of ferret portal vein. J Physiol 351: 155-167, 1984.
58. Nagaoka T, Morio Y, Casanova N, Bauer N, Gebb S, McMurtry I, and Oka M. Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol 287: L665-L672, 2004.
59. Narumiya S, Ishizaki T, and Watanabe N. Rho effectors and reorganization of actin cytoskeleton. FEBS Lett 410: 68-72, 1997.
60. Nishiki K, Tsuruoka S, Kawaguchi A, Sugimoto K, Schwartz GJ, Suzuki M, Imai M, and Fujimura A. Inhibition of Rho-kinase reduces renal Na-H exchanger activity and causes natriuresis in rat. J Pharmacol Exp Ther 304: 723-728, 2003.
61. 2+ sensitivity in α-toxin permeabilized arterial smooth muscle. Biochem Biophys Res Commun 157: 677-683, 1988.
62. Opazo Saez A, Zhang W, Wu Y, Turner CE, Tang DD, and Gunst SJ. Tension development during contractile stimulation of smooth muscle requires recruitment of paxillin and vinculin to the membrane. Am J Physiol Cell Physiol 286: C433-C447, 2004.
63. Otto B, Steusloff A, Just I, Aktories K, and Pfitzer G. Role of Rho proteins in carbachol-induced contractions in intact and permeabilized guinea-pig intestinal smooth muscle. J Physiol 496: 317-329, 1996.
64. Pollard TD, Blanchoin L, and Mullins RD. Molecular mechanisms controlling actin filament dynamics in nonmuscle cells. Annu Rev Biophys Biomol Struct 29: 545-576, 2000.
65. 2+] determines myosin phosphorylation in agonist-stimulated swine arterial smooth muscle. Circ Res 63: 593-603, 1988.
66. Ridley AJ and Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70: 389-399, 1992.
67. Robertson TP, Dipp M, Ward JP, Aaronson PI, and Evans AM. Inhibition of sustained hypoxic vasoconstriction by Y-27632 in isolated intrapulmonary arteries and perfused lung of the rat. Br J Pharmacol 131: 5-9, 2000.
68. +-induced contraction by the ROCKs inhibitor Y-27632 in vascular smooth muscle: possible involvement of ROCKs in a signal transduction pathway. J Pharm Sci 92: 56-69, 2003.
69. 2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction. Circ Res 93: 548-556, 2003.
70. Sasaki Y, Suzuki M, and Hidaka H. The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperaine as a probing molecule for Rho-kinase-involved pathway. Pharmacol Ther 93: 225-232, 2002.
71. Sauzeau V, Rolli-Derkinderen M, Lehoux S, Loirand G, and Pacaud P. Sildenafil prevents change in RhoA expression induced by chronic hypoxia in rat pulmonary artery. Circ Res 93: 630-637, 2003.
72. Seow CY and Fredberg JJ. Historical perspective on airway smooth muscle: the saga of a frustrated cell. J Appl Physiol 91: 938-952, 2001.
73. Shirazi A, Iizuka K, Fadden P, Mosse C, Somlyo AP, Somlyo AV, and Haystead TA. Purification and characterization of the mammalian myosin light chain phosphatase holoenzyme. The differential effects of the holoenzyme and its subunits on smooth muscle. J Biol Chem 269: 31598-31606, 1994.
74. Shore SA and Moore PE. Effects of cytokines on contractile and dilator responses of airway smooth muscle. Clin Exp Pharmacol Physiol 29: 859-866, 2002.
75. Small JV and Gimona M. The cytoskeleton of the vertebrate smooth muscle cell. Acta Physiol Scand 164: 341-348, 1998.
76. 2+-sensitivity and of the time course of contraction in smooth muscle: a major role of protein phosphatases? Adv Protein Phosphatases 5: 181-195, 1989.
77. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325-1358, 2003.
78. Sugai M, Hashimoto K, Kikuchi A, Inoue S, Okumura H, Matsumoto K, Goto Y, Ohgai H, Moriishi K, Syuto B, Yoshikawa K, Suginaka H, and Takai Y. Epidermal cell differentiation inhibitor ADP-ribosylates small GTP-binding proteins and induces hyperplasia of epidermis. J Biol Chem 267: 2600-2604, 1992.
79. Sylvester JT, Gottlieb JE, Rock P, and Wetzel RC. Acute hypoxic responses. In: Abnormal Pulmonary Circulation, edited by Bergofsky EF. New York: Churchill-Livingstone, 1986, p. 127-165.
80. + exchanger NHE3. Role of myosin light chain phosphorylation. J Biol Chem 275: 28599-28606, 2000.
81. Tang DD and Tan J. Downregulation of profilin with antisense oligodeoxynucleotides inhibits force development during stimulation of smooth muscle. Am J Physiol Heart Circ Physiol 285: H1528-H1536, 2003.
82. Tominaga T, Ishizaki T, Narumiya S, and Barber DL. p160ROCK mediates RhoA activation of Na-H exchange. EMBO J 17: 4712-4722, 1998.
83. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, and Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389: 990-994, 1997.
84. 2+ sensitization of arterial muscle. Am J Physiol Cell Physiol 285: C1377-C1385, 2003.
85. Vale RD and Milligan RA. The way things move: looking under the hood of molecular motor proteins. Science 288: 88-95, 2000.
86. Van Nieuw Amerongen GP and van Hinsbergh VW. Cytoskeletal effects of rho-like small guanine nucleotide-binding proteins in the vascular system. Arterioscler Thromb Vasc Biol 21: 300-311, 2001.
87. Wang Z, Jin N, Ganguli S, Swartz DR, Li L, and Rhoades RA. Rho-kinase activation is involved in hypoxia-induced pulmonary vasoconstriction. Am J Respir Cell Mol Biol 25: 628-635, 2001.
88. Wang Z, Lanner MC, Jin N, Swartz D, Li L, and Rhoades RA. Hypoxia inhibits myosin phosphatase in pulmonary arterial smooth muscle cells: role of Rho-kinase. Am J Respir Cell Mol Biol 29: 465-471, 2003.
89. 2+ sensitivity of protein kinase C-induced contraction in rabbit smooth muscle. J Physiol 535: 553-564, 2001.
90. 2+ sensitivity of contractile elements in coronary arterial smooth muscle. Am J Physiol Heart Circ Physiol 267: H614-H621, 1994.
91. 2+ sensitization. Am J Respir Cell Mol Biol 20: 1190-1200, 1999.
92. Zhang D, Wang Z, Jin N, Li L, Rhoades RA, Yancey KW, and Swartz DR. Microtubule disruption modulates the Rho-kinase pathway in vascular smooth muscle. J Muscle Res Cell Motil 22: 193-200, 2001.